(Q37909417)

25 August 2017

1 reference

title

Review on the immunogenicity and safety of PCV-13 in infants and toddlers (English)

1 reference

25 August 2017

1 reference

2

Shabir A Madhi

1 reference

25 August 2017

Marta C Nunes

1

0 references

language of work or name

1 reference

1 July 2011

1 reference

Expert Review of Vaccines

25 August 2017

1 reference

25 August 2017

10

1 reference

25 August 2017

7

1 reference

25 August 2017

951-980

1 reference

Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates

25 August 2017

1 reference

Serological criteria for evaluation and licensure of new pneumococcal conjugate vaccine formulations for use in infants

21 January 2018

1 reference

The contribution of specific pneumococcal serogroups to different disease manifestations: implications for conjugate vaccine formulation and use, part II.

21 January 2018

1 reference

Differential effects of pneumococcal vaccines against serotypes 6A and 6C.

21 January 2018

1 reference

Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study

21 January 2018

1 reference

Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group

21 January 2018

1 reference

Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than five years of age for prevention of pneumonia

21 January 2018

1 reference

Efficacy of a pneumococcal conjugate vaccine against acute otitis media

21 January 2018

1 reference

A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection

21 January 2018

1 reference

Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine

21 January 2018

1 reference

Decline in Invasive Pneumococcal Disease after the Introduction of Protein–Polysaccharide Conjugate Vaccine

21 January 2018

1 reference

Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I.

21 January 2018

1 reference

Geographical differences in invasive pneumococcal disease rates and serotype frequency in young children

21 January 2018

1 reference

Systematic evaluation of serotypes causing invasive pneumococcal disease among children under five: the pneumococcal global serotype project

21 January 2018

1 reference

Challenges in the evaluation and licensing of new pneumococcal vaccines, 7-8 July 2008, Ottawa, Canada

21 January 2018

1 reference

Efficacy and safety of seven-valent conjugate pneumococcal vaccine in American Indian children: group randomised trial

21 January 2018

1 reference

Estimating the protective concentration of anti-pneumococcal capsular polysaccharide antibodies

21 January 2018

1 reference

A multi-laboratory evaluation of an enzyme-linked immunoassay quantitating human antibodies to Streptococcus pneumoniae polysaccharides

21 January 2018

1 reference

Safety and immunogenicity of a 13-valent pneumococcal conjugate vaccine compared to those of a 7-valent pneumococcal conjugate vaccine given as a three-dose series with routine vaccines in healthy infants and toddlers

21 January 2018

1 reference

Immunogenicity and reactogenicity of a 13-valent-pneumococcal conjugate vaccine administered at 2, 4, and 12 months of age: a double-blind randomized active-controlled trial

21 January 2018

1 reference

A dynamic model of pneumococcal infection in the United States: implications for prevention through vaccination.

21 January 2018

1 reference

First report of putative Streptococcus pneumoniae serotype 6D among nasopharyngeal isolates from Fijian children

21 January 2018

1 reference

Discovery of a new capsular serotype (6C) within serogroup 6 of Streptococcus pneumoniae

21 January 2018

1 reference

PCR-based quantitation and clonal diversity of the current prevalent invasive serogroup 6 pneumococcal serotype, 6C, in the United States in 1999 and 2006 to 2007.

21 January 2018

1 reference

Increase in prevalence of Streptococcus pneumoniae serotype 6C at Eight Children's Hospitals in the United States from 1993 to 2009.

21 January 2018

1 reference

Increase in the prevalence of the newly discovered pneumococcal serotype 6C in the nasopharynx after introduction of pneumococcal conjugate vaccine

21 January 2018

1 reference

Immunogenicity, safety and tolerability of heptavalent pneumococcal conjugate vaccine administered at 3, 5 and 11 months post-natally to pre- and full-term infants

21 January 2018

1 reference

Effectiveness of a 2+1 dose schedule pneumococcal conjugate vaccination programme on invasive pneumococcal disease among children in Norway

21 January 2018

1 reference

Effect of reduced-dose schedules with 7-valent pneumococcal conjugate vaccine on nasopharyngeal pneumococcal carriage in children: a randomized controlled trial

21 January 2018

1 reference

Safety profile of pneumococcal conjugate vaccines: systematic review of pre- and post-licensure data

21 January 2018

1 reference

Immunogenicity, reactogenicity and safety of a 7-valent pneumococcal conjugate vaccine (PCV7) concurrently administered with a DTPa-HBV-IPV/Hib combination vaccine in healthy infants.

21 January 2018

1 reference

The safety, reactogenicity and immunogenicity of a 7-valent pneumococcal conjugate vaccine (7VPnC) concurrently administered with a combination DTaP-IPV-Hib vaccine

21 January 2018

1 reference

Recommendations for the prevention of Streptococcus pneumoniae infections in infants and children: use of 13-valent pneumococcal conjugate vaccine (PCV13) and pneumococcal polysaccharide vaccine (PPSV23).

21 January 2018

1 reference

10-valent pneumococcal nontypeable Haemophilus influenzae PD conjugate vaccine: Synflorix.

21 January 2018

1 reference

Serum serotype-specific pneumococcal anticapsular immunoglobulin g concentrations after immunization with a 9-valent conjugate pneumococcal vaccine correlate with nasopharyngeal acquisition of pneumococcus

21 January 2018

1 reference

Immunogenicity and Safety of Measles-Mumps-Rubella, Varicella and Haemophilus influenzae Type b Vaccines Administered Concurrently With a Fourth Dose of Heptavalent Pneumococcal Conjugate Vaccine Compared With the Vaccines Administered Without Heptav

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ERV.11.76

1 reference

25 August 2017

1 reference

PubMed ID

21806394